Putative susceptibility markers of coronary artery disease: Association between VDR genotype, smoking, and aromatic DNA adduct levels in human fight atrial tissue

FASEB Journal

Volumn 12, Issue 13, 1998, Pages 1409-1417

  Van Schooten, F J ^a   Hirvonen, A ^a,b   Maas, L M ^a   De Mol, B A ^a,c   Kleinjans, J C S ^a   Bell, D A ^a,d   Durrer, J D ^a,e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c Department of Cardiothoracic Surgery ^*  (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

CAD; Genetic polymorphisms; Smoking related DNA adducts

Indexed keywords

BIOLOGICAL MARKER; DNA; GLUTATHIONE TRANSFERASE; VITAMIN D RECEPTOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DNA ADDUCT; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SMOKING;

EID: 0031717255     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.12.13.1409     Document Type: Article

References (56)

1. Hoffman, D., and Hecht, S. S. (1990) Advances in tobacco carcinogenesis. In Chemical Carcinogenesis and Mutagenesis (Cooper, C. S., and Grover, P. L., eds) pp. 63-102, Raven Press, New York
2. Bridges, B. A., Bowyer, D. E., Hansen, E. S., Penn, A., and Wakabayashi, K. (eds) (1990) Report of ICPEMC Subcommittee 7/ The possible involvement of somatic mutations in the development of atherosclerotic plaques (special issue). Mutat. Res. 239, 143-187
3. Benditt, E. P., and Benditt, J. M. (1973) Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA 70, 1753-1756
4. Penn, A., Garte, S. J., Warren, L., Nesta, D., and Mindich, B. (1986) Transforming gene in human atherosclerotic plaque DNA. Proc. Natl. Acad. Sci. USA 83, 7951-7955
5. Hall, M., and Grover, P. L. (1990). Polycyclic aromatic hydrocarbons: metabolism, activation, tumour initiaion. In Chemical Carcinogensis and Mutations (Cooper, C. S., and Grover, P. L., Eds) pp. 327-372, Raven Press, New York
6. Everson, R. B., Randerath, E., Santella, R. M., Avitts, T. A., Weinstein, I. B., and Randerath, K. (1988) Quantitative associations between DNA damage in human placenta and maternal smoking and birth wieght. J. Natl. Cancer Inst. 80, 567-576
7. Phillips, D. H., Hewer, A., Martin, C. N., Garner, R. C., and King, M. M. (1988) Correlation of DNA adduct levels in human lung with cigarette smoking. Nature (London) 33b, 790-792
8. Cuzick, J., Routledge, M. N., Jenkins, D., and Garner, R. C. (1990) DNA adducts in different tissues of smokers and nonsmokers. Int. J. Cancer 45, 673-678
9. Van Schooten, F. J., Hillebrand, M. J. X., Van Leeuwen, F. E., Lutgerink, J. L., Van Zandwijk, N., Jansen, H. M., and Kriek, E. (1990) Polycyclic aromatic hydrocarbon DNA adducts in lung tissue from lung cancer patients. Carcinogenesis, 11, 1677-1681
10. Lewtas, J., Mumford, J., Everson, R. B., Hulka, B., Wilcosky, T., Kozumbo, W., Thompson, C., George, M., Dobias, L., Sram, R., Li, X. M., and Gallagher, J. (1993) Comparison of DNA adducts from exposure to complex mixtures in various human tissues and experimental systems. Environ. Health Perspect. 99, 89-97
11. Izzotti, A., D'Agostini, F., Bagnasco, M., Scatolini, L., Rovida, A., Balansky, R. M., Cesarone, C. F., and Deflora, S. (1994) Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. Cancer Res. 54 (Suppl.), S1994-S1998
12. De Flora, S., Izzotti, A., Randerath, K., Randerath, E., Bartsch, H., Nair, J., Balansky, R., Van Schooten, F. J., Degan, P., Fronza, G., Walsh, D., and Lewtas, J. (1996) DNA adducts and chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine. Mutat. Res. 366, 197-238
13. De Flora, S., Izzotti, A., Walsh, A., Degan, P., Petrilli, G. L., and Lewtas, J. (1997) Molecular epidemiology of atherosclerosis. FASEB J. 11, 1021-1031
14. Schulte, P. A., Rothman, N., and Austin, M. A. (1993) Cardiovascular Disease. In Molecular Epidemiology. Principles and Practices (Schulte, P. A., and Perera, F. P., eds) pp. 341-363, Academic Press, San Diego
15. Mannervik, B., Alin, P., Guthenberg, C., Jensson, H., Tahir, M. K., Warholm, M., and Jornall, H. (1985) Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc. Natl. Acad. Sci. USA 82, 7202-7206
16. Meyer, D. J., Coles, B., Pemble, S. E., Gilmore, K. S., Fraser, G. M., and Ketterer, B. (1991) Theta, a new class of glutathione transferase purified from rat and man. Biochem. J. 274, 409-414
17. Board, P. G. (1991) Biochemical genetics of glutathione S-transferase in man. Am. J. Hum. Genet. 33, 36-43
18. Seidegard, J., Pero, R. W., Markowitz, M. M., Roush, G., Miller, D. G., and Beattie, J. (1990) Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer. Carcinogenesis 11, 33-36
19. Hirvonen, A., Husgafvel- Pursiainen, K., Anttila, S., and Vainio, H. (1993) The GSTM1 null genotypes as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14, 1479-1481
20. Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L., and Lucier, G. W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase MI (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85, 1159-1164
21. Pemble, S., Schroeder, K. R., Spencer, S. R., Meyer, D. J., Hallier, E., Bolt, H. M., Ketterer, B., and Taylor, J. B. (1994) Human glutathione S-tranferase theta (GSTT1): cDNA cloning and the characterisation of a genetic polymorphism. Biochem. J. 300, 271-276
22. Warwick, A., Sarhanis, P., Redman, C., Pemble, S., Taylor, J. B., Ketterer, B., Jones, P., Alldersea, J., Gilford, J., Yengi, L., Fryer, A., and Strange, R. C. (1994) Theta class glutathione 5-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: Interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 15, 2841-2845
23. Morrison, N. A., Qi, J. C., Tokita, A., Kelly, P. J., Crofts, L., Nguyen, T. V., Sambrook, P. N., and Eisman, J. A. (1994) Prediction of bone density from vitamin D receptor alleles. Nature (London) 367, 284-287
24. Taylor, J. A., Hirvonen, A., Watson., M., Pittman, G., Mohler, J. L., and Bell, D. A. (1996) Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 56, 4108-4110
25. Sandgren, M. E., Bronnegard, M., and De Luca, H. F. (1991) Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. Biochem. Biophys. Res. Commun. 181, 611-616
26. Studzinski, G. P., and Moore, D. C. (1995) Sunlight - can it prevent as well as cause cancer? Cancer Res. 55, 4014-4022.
27. Scragg, R., Jackson, R., Holdaway, I. M., Lim, T., and Beaglehole, R. (1990) Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int. J. Epidemiol. 19, 559-563
28. Morrison, N. A., Yeoman, R., Kelly, P. J., and Eisman, J. A. (1992) Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc. Natl. Acad. Sci. USA 89, 6665-6669
29. 32P- postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7, 1543-1551
30. 32P-Postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures. Mutat. Res. 378, 65-75
31. Randerath, E., Mittal, D., and Randerath, K. (1988) Tissue distribution of covalent DNA damage in mice treated dermally with cigarette 'tar': preference for lung and heart. Carcinogenesis 9, 75-80
32. 32P-postlabeling. J. Natl. Cancer Inst. 81, 341-347
33. Dunn, B. P., Vedal, S., San, R. H. C., Kwan, W.-F., Nelems, B., Enarson, D. A., and Stich, H. F. (1991) DNA adducts in bronchial biopsis. Int. J. Cancer 48, 485-492
34. Phillips, D. H., Schoket, B., Hewer, A., Bailey, E., Kostic, S., and Vinze, I. (1990) Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int. J. Cancer 46, 569-575
35. Izzotti, A., De Flora, S., Petrilli, G., Gallagher, J., Rojas, M., Alexandrov, K., Bartsch, H., and Lewtas, J. (1995) Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts. Cancer Epidemiol. Biomarkers Prev. 4, 105-110
36. Thirman, M. J., Albrecht, J. H., Kreuger, M. A., Erickson, R. R., Cherwitz, D. L., Park, S. S., Gelhoin, H. V., and Holtzman, J. L. (1994) Induction of cytochrome CYPIA1 and formation of toxic metabolites of benzo (a) pyrene by rat aorta: a possible role in artherogenesis. Proc. Natl. Acad. Sci. USA 91, 5397-5401
37. Ginsberg, G. L., and Atherholt, T. B. (1990) DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol epoxide. Cancer Res. 50, 1189-1194
38. Gaubatz, J. W. (1997) Heart damage associated with cooked meat mutagens. Nutr. Biochem. 8, 490-496
39. Sadhu, D., and Ramos, K. (1993) Modulation by retinoic acid of spontaneous and benzo(a)pyrene-induced C-HA-RAS expression. In Antimutagenesis and Anticarcinogenesis Mechanism III (Bronzetti, G., Hayatsu, H., De Flora, S., and Waters, M. D., and Shankel, D. M., eds) pp. 263-268, Plenum Press, New York
40. Harris, C. C. (1993) p53 - At the crossroads of molecular carcinogenesis and risk assessment. Science 262, 1980-1981
41. Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., and Epstein, S. E. (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391-394
42. D'Agostini, F., Fronza, G., Campomenosi, P., Izzotti, A., Petrilli, G. L., Abbondandolo, A., and De Flora, S. (1995) Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement. Cancer Epidemiol. Biomarkers Prev. 4, 111-115
43. Gordon, D., Reidy, M. A., Benditt, E. P., and Schwartz, S. M. (1990) Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. USA 87, 4600-4604
44. Grainger, D. J., Kirschenlohr, H. L., Metcalf, J. C., Weissberg, P. L., Wade, D. P., and Lawn, R. M. (1993) Proliferation of human smooth cells promoted by lipoprotein(a). Science 260, 1655-1658
45. Troll, W., Belman, S., and Frenkel, K. (1993) Cholesterol: a contributor to tumor promotion (abstr.). In 4th International Conference on Anticarcinogenesis and Radiation Protection, p. 72, Baltimore, Maryland
46. Putman, J. B., Sweeney, M. S., Colon, R., Lanza, R. A., Frazier, O. H., and Cooley, D. A. (1991) Primary cardiac sarcomas. Ann. Thorac. Surg. 51, 906-910
47. Hartz, A. J., Anderson, A. J., Brooks, H. L., Manley, J. C., Parent, G. D., and Barboriak, J. J. (1984) The association of smoking with cardiomyopathy. N. Engl. J. Med. 311, 1201-1206
48. Wells, A. J. (1994) Passive smoking as a cause of heart disease. J. Am. Coll. Cardiol. 24, 546-554
49. Glantz, S. A., and Parmley, W. W. (1995) Passive smoking and heart disease: Mechanisms and risk. J. Am. Med. Assn. 273, 1047-1053
50. Brown, G., Albers, J. J., Fisher, L. D., Schaeffer, S. M., Lin, J. T., Kaplan, C., Zhao, X. Q., Bisson, B. D., Fitzpatrick, V., and Dodge, H. T. (1990) Regression of coronary artery disease as a result, of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med. 323, 1289-1298
51. Dahlen, G. H., Guyton, J. R., Attar, M., J. A., F., Kautz, J. A., and Gotto, A. M. (1986) Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74, 758-765
52. Kannel, W. B., Castelli, W. P., Gordon, T., and McNamara, P. M. (1971) Serum cholesterol, lipoproteins, and risk of coronary heart disease. Ann. Int. Med. 74, 1-21
53. Stamler, J. S., Wentworth, D., and Neaton, J. D. (1986) Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous or graded? Findings in 356,222 primary screenings of the Multiple Risk Factor Intervention Trial (MRFIT). J. Am. Med. Assn. 256, 2823-2828
54. Verschuren, W. M. M., Jacobs, D. R., Bloemberg, B. P. M., Kromhout, D., Menotti, A., Aravanis, C., Blackburn, H., Buzina, R., Dontas, A. S., Fidanza, F., Karvonen, M. J., Nedeljkovic, S., Nissinen, A., and Toshima, H. (1995) Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five- year follow-up of the seven countries study. J. Am. Med. Assn. 274, 131-136
55. Scragg, R., Holdaway, I., Jackson, R., and Lim, T. (1992) Plasma 25- hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. Ann. Epidemiol. 2, 679-703
56. Fraser, D. R. (1995) Vitamin D. Lancet 345, 104-107